Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 20/20 | 0.44 |
| ▸ | TGFBR2 | P37173 | 3/20 | 0.41 |
| ▸ | MAP3K20 | Q9NYL2 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 3/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23408256 | 0.80 | TGFBR1 (0.51) | TGFBR1TGFBR2MAP3K20CYP2D6THRB | |
| SCHEMBL23408112 | 0.73 | TGFBR1 (0.43) | TGFBR1TGFBR2MAP3K20CYP2D6MTOR | |
| SCHEMBL25084602 | 0.73 | TGFBR1 (0.39) | TGFBR1TGFBR2MAP3K20CYP2D6THRB | |
| SCHEMBL30155819 | 0.73 | TGFBR1 (0.39) | TGFBR1TGFBR2MAP3K20CYP2D6THRB | |
| SCHEMBL23408109 | 0.72 | TGFBR1 (0.43) | TGFBR1CYP2D6MTORMAPK14 | |
| SCHEMBL23408259 | 0.71 | TGFBR1 (0.55) | TGFBR1TGFBR2MAP3K20CYP2D6MTOR | |
| SCHEMBL23408111 | 0.70 | TGFBR1 (0.44) | TGFBR1MTORMAPK14 | |
| SCHEMBL23408113 | 0.69 | TGFBR1 (0.42) | TGFBR1TGFBR2MAP3K20MTORMAPK14 | |
| SCHEMBL23407919 | 0.69 | TGFBR1 (0.46) | TGFBR1CYP2D6MTORMAPK14 | |
| SCHEMBL30156584 | 0.67 | TGFBR1 (0.49) | TGFBR1TGFBR2MAP3K20CYP2D6THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021102468-A1 | SUBSTITUTED 1,5-NAPHTHYRIDINES OR QUINOLINES AS ALK5 INHIBITORS | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2021-05-27 | — | — | WO | disclosed |